NRX Pharmaceuticals, Inc. Warrant
NRXPW
NRXPW
2 hedge funds and large institutions have $4.29K invested in NRX Pharmaceuticals, Inc. Warrant in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
YCM
1
Yakira Capital Management
Westport,
Connecticut
| $4.28K | 17,129 | – | – |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $4 | 15 | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| – | – | -3,356 | Closed |
|
|
CFGS
4
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|